Geographic and racial/ethnic differences in HFE mutation frequencies in the hemochromatosis and iron overload screening (HEIRS) study

Ethnicity and Disease

Volumn 16, Issue 4, 2006, Pages 815-821

  Acton, Ronald T ^a   Barton, James C ^b   Snively, Beverly M ^c   McLaren, Christine E ^d   Adams, Paul C ^e   Harris, Emily L ^f   Speechley, Mark R ^e   McLaren, Gordon D ^d,g   Dawkins, Fitzroy W ^h   Leiendecker Foster, Catherine ⁱ   Holup, Joan L ^j   Balasubramanyam, Aarthi ^c  

^a University of Alabama at Birmingham   (United States)

^b SOUTHERN IRON DISORDERS CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f CENTER FOR HEALTH RESEARCH   (United States)

^g VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^h HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^j Center for Health Research   (United States)

more..

Author keywords

Geographic differences; HFE; Race ethnicity

Indexed keywords

HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ABORIGINE; ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; CAUCASIAN; CLINICAL TRIAL; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; HEMOCHROMATOSIS; HISPANIC; HUMAN; IRON OVERLOAD; MALE; MULTICENTER STUDY; MUTATION; NEGRO; NORTH AMERICA; RACE; STATISTICS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HISPANIC AMERICANS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INDIANS, NORTH AMERICAN; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MUTATION; NORTH AMERICA; OCEANIC ANCESTRY GROUP;

EID: 34249746554     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med. 1998;129(11):932-939.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet. 1996;13(4):399-408. (Pubitemid 26256612)
3. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test. 2000;4(2):183-198. (Pubitemid 30618706)
4. Barton JC, Acton RT. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama. Genet Test. 2000;4(2):199-206.
5. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000;133(5):329-337.
6. Phatak PD, Ryan DH, Cappuccio J, et al. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis. 2002;29(1):41-47.
7. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening of a racially diverse population. N Engl J Med. 2005;352:1769-1778.
8. McLaren CE, Barton JC, Adams PC, et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci. 2003;325(2):53-62.
9. Barton JC, Acton RT, Dawkins FW, et al, for the Hemochromatosis and Iron Overload Screening Study Research Investigators. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Genet Test. 2005;9(3):231-241.
10. Adams PC, Walker AP, Acton RT. A primer for predicting risk of disease in HFE-linked hemochromatosis. Genet Test. 2001;5(4):311-316. (Pubitemid 34258407)
11. Barton JC, Shih WW, Sawada-Hirai R, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis. 1997;23(1):135-145. (Pubitemid 27310965)
12. MacClenahan K, Moran R, McDermott S, Longshore J. Prevalence of hereditary hemochromatosis mutations in the upper Savannah region of South Carolina. Proc Greenwood Genet Center. 2000;19:45-50.
13. Bradley LA, Johnson DD, Palomaki GE, Haddow JE, Robertson NH, Ferrie RM. Hereditary hemochromatosis mutation frequencies in the general population. J Med Screen. 1998;5(1):34-36. (Pubitemid 28272357)
14. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001;285(17):2216-2222. (Pubitemid 32416767)
15. Girouard J, Giguere Y, Delage R, Rousseau F. Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients. Hum Mol Genet. 2002;11(2):185-189. (Pubitemid 34157010)
16. Cogswell ME, Gallagher ML, Steinberg KK, et al. HFE genotype and transferrin saturation in the United States. Genet Med. 2003;5(4):304-310.
17. Phatak PD, Sham RL, Raubertas RF, et al. Prevalence of hereditary hemochromatosis in 16,031 primary care patients. Ann Intern Med. 1998;129(11):954-961.
18. Barton JC, Cheatwood SM, Key TJ, Acton RT. Hemochromatosis detection in a health screening program at an Alabama forest products mill. J Occup Environ Med. 2002;44(8):745-751.
19. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med. 1999;107(1):30-37. (Pubitemid 29328279)
20. Acton RT, Barton JC, Bell DS, Go RC, Roseman JM. HFE mutations in African American women with non-insulin-dependent diabetes mellitus. Ethn Dis. 2001;11(4):578-584.
21. Barton JC, Acton RT, Lovato L, et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and Whites in the Hemochromatosis and Iron Overload Screening Study. Clin Genet. 2006;69(1):48-57. (Pubitemid 43372223)
22. Barton EH, Barton JC, Hollowell WW, Acton RT. Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethn Dis. 2004;14(1):73-81. (Pubitemid 38262749)
23. Ajioka RS, Jorde LB, Gruen JR, et al. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Gen. 1997;601:439-1447.
24. Tokunaga K, Ohashi J, Bannai M, Juji T. Genetic link between Asians and native Americans: evidence from HLA genes and haplotypes. Hum Immunol. 2001;62(9):1001-1008. (Pubitemid 32835064)
25. Acton RT, Harman L, Go RC, Tseng ML, Bias W. Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North Carolina. Transplant Proc. 1993;25(4):2404-2407.
26. Kuffner T, Whitworth W, Jairam M, McNicholl J. HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies. Hum Immunol. 2003;64(6):639-647. (Pubitemid 36706059)
27. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol. 2001;62(9):1009-1030. (Pubitemid 32835065)
28. Ryan E, O'Keane C, Crowe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis. 1998;24(4):428-432.
29. Willis G, Jennings B, Goodman E, Fellows I, Wimperis J. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis. 1997;23:288-291. (Pubitemid 27469463)
30. Mercier G, Bathelier C, Lucotte G. Frequency of the C282Y mutation of hemochromatosis in five French populations. Blood Cells Mol Dis. 1998;24(2):165-166. (Pubitemid 28365735)
31. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis. 2003;31(2):262-267.
32. Acton RT, Barton EH, Hollowell WW, Dreibelbis AL, Go RC, Barton JC. Ancestry reported by White adults with cutaneous melanoma and control subjects in central Alabama. BMC Cancer. 2004;4:47.
33. Barton JC, Acton RT. HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama. BMC Med Genet. 2002;3(1):9.
34. Canada Statistics. Profile of citizenship, immigration, birthplace, generation status, ethnic origin, visible minorities and aboriginal peoples, for Canada, Provinces, Territories, Census divisions and Census subdivisions. 2001 Census. London, Canada: Canada Statistics; 2001.Table 95F0489XCB2001001.
35. Barnholtz-Sloan JS, Chakraborty R, Sellers TA, Schwartz AG. Examining population stratification via individual ancestry estimates versus self-reported race. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1545-1551. (Pubitemid 40807360)
36. Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis. 1999;25(3-4):147-155. (Pubitemid 29521416)
37. Acton RT, Barton JC. Hereditary hemochromatosis. In: Fuchs J, Maurizio P, eds. Encyclopedia of Medical Genomics and Proteomics. New York, NY: Marcel Dekker; 2004:605-611.
38. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood. 2005;106(12):3710-3717. (Pubitemid 41739004)